Wet macular degeneration

Wet macular degeneration is an extremely harmful disease. If it is not treated effectively in time, it may cause other complications and even endanger life. From the perspective of clinical treatment effects, surgical treatment, laser treatment, transpupillary thermotherapy, etc. are quite effective. In addition, the appropriate use of digitalis glycosides on the retina and choroid can also achieve certain effects. Patients need to determine the final treatment plan based on the examination results.

1. Surgery for macular degeneration

Treatment methods for wet macular degeneration: surgical treatment: such as resection of subretinal neovascularization, macular translocation surgery, etc. However, the surgery is quite risky and is rarely used nowadays. Because if serious complications occur after the operation, irreparable damage will be caused to the macula, we should try to adopt treatments with a higher insurance factor and better safety.

2. Laser treatment of macular degeneration

Treatment methods for wet macular degeneration: Laser therapy: It is only suitable for lesions that are not in the center of the macula, but outside the fovea and have clear boundaries, because its principle is to use a high-energy laser beam to destroy the lesions, but at the same time it will destroy normal retinal tissue. If the laser hits the fovea, irreversible vision damage will occur. Moreover, more than 50% of the lesions will recur.

3. Transpupillary thermotherapy (TTT)

The treatment for wet macular degeneration is transpupillary thermotherapy, but the problem is that both normal and abnormal blood vessels will be damaged. New blood vessels are relatively fragile, and the first to respond to thermotherapy are the unhealthy new blood vessels, followed by some normal blood vessels. Therefore, the irradiation should be stopped before the normal tissue is damaged. This control is quite difficult, and its therapeutic effect has not been confirmed by clinical trials abroad. Lesions in the fovea are also not suitable for TTT treatment.

4. Digitalis glycosides can selectively concentrate in the retina and choroid

Treatment for wet macular degeneration. Xanthoglobin can activate pigment epithelial enzymes (such as sodium-potassium activated adenotriphosphatase Na-K ATPase), which can enhance the function of pigment epithelial cells, thereby enhancing their ability to digest and phagocytize photoreceptor cell outer segment substances, while also enhancing their ability to transport nutrients, ensure the energy supply of photoreceptor cells, protect photoreceptor cells and choroidal capillaries, prevent the retina from being damaged and atrophied, and avoid or alleviate and treat macular degeneration.